These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 19104176

  • 1. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
    Ploeger BA, Smeets J, Strougo A, Drenth HJ, Ruigt G, Houwing N, Danhof M.
    Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
    Eleveld DJ, Kuizenga K, Proost JH, Wierda JM.
    Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
    [Abstract] [Full Text] [Related]

  • 4. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS.
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [Abstract] [Full Text] [Related]

  • 5. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H.
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [Abstract] [Full Text] [Related]

  • 6. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A, Ho J, Wong J, Yin L, Chung F.
    Anesth Analg; 2010 Apr 01; 110(4):1239. PubMed ID: 20357160
    [Abstract] [Full Text] [Related]

  • 7. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar 01; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 8. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 9. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK.
    Anesthesiology; 2009 Feb 01; 110(2):284-94. PubMed ID: 19194156
    [Abstract] [Full Text] [Related]

  • 10. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M.
    Anesthesiology; 2007 Aug 01; 107(2):239-44. PubMed ID: 17667567
    [Abstract] [Full Text] [Related]

  • 11. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME.
    Anesth Analg; 2009 Mar 01; 108(3):846-51. PubMed ID: 19224792
    [Abstract] [Full Text] [Related]

  • 12. Sugammadex in clinical practice.
    Mirakhur RK.
    Anaesthesia; 2009 Mar 01; 64 Suppl 1():45-54. PubMed ID: 19222431
    [Abstract] [Full Text] [Related]

  • 13. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
    Hemmerling TM, Zaouter C, Geldner G, Nauheimer D.
    Ann Card Anaesth; 2010 Mar 01; 13(3):206-16. PubMed ID: 20826961
    [Abstract] [Full Text] [Related]

  • 14. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M.
    Anesthesiology; 2009 May 01; 110(5):1020-5. PubMed ID: 19387176
    [Abstract] [Full Text] [Related]

  • 15. Preclinical pharmacology of sugammadex.
    Bom A, Hope F, Rutherford S, Thomson K.
    J Crit Care; 2009 Mar 01; 24(1):29-35. PubMed ID: 19272536
    [Abstract] [Full Text] [Related]

  • 16. Clinical implications of sugammadex.
    Caldwell JE, Miller RD.
    Anaesthesia; 2009 Mar 01; 64 Suppl 1():66-72. PubMed ID: 19222433
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
    Zwiers A, van den Heuvel M, Smeets J, Rutherford S.
    Clin Drug Investig; 2011 Mar 01; 31(2):101-11. PubMed ID: 21067251
    [Abstract] [Full Text] [Related]

  • 18. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M.
    Anesth Analg; 2007 Mar 01; 104(3):575-81. PubMed ID: 17312211
    [Abstract] [Full Text] [Related]

  • 19. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ, Woo T, Assaid CA, Lupinacci RJ, Lemmens HJ, Blobner M, Khuenl-Brady KS.
    J Clin Anesth; 2017 Sep 01; 41():84-91. PubMed ID: 28802619
    [Abstract] [Full Text] [Related]

  • 20. Neuromuscular transmission: new concepts and agents.
    de Boer HD.
    J Crit Care; 2009 Mar 01; 24(1):36-42. PubMed ID: 19272537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.